Berry Genomics Co (000710.SZ) Stock Price

Berry Genomics Co Price

SZSE·CLOSED
7.87CNY+0.27 (+3.49 %)
Market closed

Over the last 19 years Berry Genomics Co grew revenue by 11.8% annually, reaching 1.08 B CNY. Earnings per share have grown at 37.1% per year over the last 14 years. For Berry Genomics Co, the net margin of -17.8% is down versus 13.7% a few years ago. The consensus 12-month price target for Berry Genomics Co is 77.27 CNY, about 881.8% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 7% above its 52-week low.

Berry Genomics Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Berry Genomics Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Berry Genomics Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Berry Genomics Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Berry Genomics Co Stock Price History
DateBerry Genomics Co Price
7/14/20267.87 CNY
7/13/20267.60 CNY
7/10/20267.83 CNY
7/9/20267.44 CNY
7/8/20267.52 CNY
7/7/20267.65 CNY
7/6/20268.05 CNY
7/3/20268.03 CNY
7/2/20267.85 CNY
7/1/20267.88 CNY
6/30/20267.46 CNY
6/29/20267.64 CNY
6/26/20267.37 CNY
6/25/20267.68 CNY
6/24/20267.84 CNY
6/23/20268.13 CNY
6/22/20267.58 CNY
6/18/20267.94 CNY
6/17/20267.84 CNY
6/16/20267.99 CNY
6/15/20268.02 CNY
6/12/20268.12 CNY
6/11/20267.93 CNY
6/10/20268.11 CNY
6/9/20268.27 CNY
6/8/20268.19 CNY
6/5/20268.32 CNY
6/4/20268.30 CNY
6/3/20268.55 CNY
6/2/20268.72 CNY
6/1/20268.98 CNY
5/29/20268.82 CNY
5/28/20268.86 CNY
5/27/20268.77 CNY
5/26/20269.14 CNY
5/25/20269.42 CNY
5/22/20269.48 CNY
5/21/20269.57 CNY
5/20/202610.14 CNY
5/19/202610.46 CNY
5/18/202610.60 CNY
5/15/202610.41 CNY
5/14/202610.30 CNY
5/13/202610.59 CNY
5/12/202610.72 CNY
5/11/202611.41 CNY
5/8/202610.99 CNY
5/7/20269.99 CNY
5/6/202610.00 CNY
4/30/20269.99 CNY
4/29/20269.92 CNY
4/28/20269.75 CNY
4/27/20269.86 CNY
4/24/20269.68 CNY
4/23/20269.70 CNY
4/22/20269.97 CNY
4/21/20269.95 CNY
4/20/202610.23 CNY
4/17/202610.06 CNY
4/16/202610.32 CNY
4/15/202610.27 CNY
4/14/202610.26 CNY
4/13/202610.18 CNY
4/10/202610.35 CNY
4/9/202610.35 CNY
4/8/202610.69 CNY
4/7/202610.48 CNY
4/3/202610.31 CNY
4/2/202610.81 CNY
4/1/202610.72 CNY
3/31/202610.32 CNY
3/30/202610.44 CNY
3/27/202610.41 CNY
3/26/202610.05 CNY
3/25/202610.27 CNY
3/24/202610.36 CNY
3/23/20269.81 CNY
3/20/202610.50 CNY
3/19/202610.99 CNY
3/18/202611.40 CNY
3/17/202611.13 CNY
3/16/202611.36 CNY
3/13/202611.35 CNY
3/12/202611.48 CNY
3/11/202611.70 CNY
3/10/202611.91 CNY
3/9/202611.77 CNY
3/6/202611.82 CNY
3/5/202611.54 CNY
3/4/202611.31 CNY
3/3/202611.41 CNY
3/2/202611.85 CNY
2/27/202612.43 CNY
2/26/202612.36 CNY
2/25/202612.49 CNY
2/24/202612.28 CNY
2/13/202612.30 CNY
2/12/202612.35 CNY
2/11/202612.52 CNY
2/10/202612.70 CNY
2/9/202612.55 CNY
2/6/202612.63 CNY
2/5/202612.24 CNY
2/4/202612.28 CNY
2/3/202612.21 CNY
2/2/202611.83 CNY
1/30/202612.05 CNY
1/29/202612.54 CNY
1/28/202612.46 CNY
1/27/202612.98 CNY
1/26/202613.31 CNY
1/23/202613.19 CNY
1/22/202612.94 CNY
1/21/202612.66 CNY
1/20/202612.68 CNY
1/19/202612.64 CNY
1/16/202612.77 CNY
1/15/202613.50 CNY
1/14/202615.00 CNY
1/13/202614.45 CNY
1/12/202613.14 CNY
1/9/202612.66 CNY
1/8/202612.22 CNY
1/7/202611.70 CNY
1/6/202611.98 CNY
1/5/202612.08 CNY
12/31/202511.29 CNY
12/30/202511.16 CNY
12/29/202511.25 CNY
12/26/202511.35 CNY
12/25/202511.51 CNY
12/24/202511.35 CNY
12/23/202511.28 CNY
12/22/202511.58 CNY
12/19/202511.68 CNY
12/18/202511.75 CNY
12/17/202511.31 CNY
12/16/202511.05 CNY
12/15/202511.19 CNY
12/12/202511.18 CNY
12/11/202511.10 CNY
12/10/202511.37 CNY
12/9/202511.45 CNY
12/8/202511.58 CNY
12/5/202511.61 CNY
12/4/202511.43 CNY
12/3/202511.69 CNY
12/2/202511.96 CNY
12/1/202512.16 CNY
11/28/202512.23 CNY
11/27/202512.08 CNY
11/26/202512.18 CNY
11/25/202512.23 CNY
11/24/202511.97 CNY
11/21/202511.59 CNY
11/20/202512.69 CNY
11/19/202513.96 CNY
11/18/202513.93 CNY
11/17/202513.66 CNY
11/14/202513.80 CNY
11/13/202513.77 CNY
11/12/202513.92 CNY
11/11/202513.53 CNY
11/10/202513.66 CNY
11/7/202513.58 CNY
11/6/202513.79 CNY
11/5/202514.13 CNY
11/4/202513.56 CNY
11/3/202513.89 CNY
10/31/202513.09 CNY
10/30/202512.85 CNY
10/29/202512.84 CNY
10/28/202512.89 CNY
10/27/202512.82 CNY
10/24/202512.80 CNY
10/23/202512.87 CNY
10/22/202513.00 CNY
10/21/202513.22 CNY
10/20/202512.74 CNY
10/17/202512.60 CNY
10/16/202512.88 CNY
10/15/202513.03 CNY
10/14/202512.74 CNY
10/13/202512.91 CNY
10/10/202513.13 CNY
10/9/202513.18 CNY
9/30/202512.97 CNY
9/29/202512.88 CNY
9/26/202512.81 CNY
9/25/202513.00 CNY
9/24/202513.08 CNY
9/23/202512.77 CNY
9/22/202513.11 CNY
9/19/202513.21 CNY
9/18/202513.77 CNY
9/17/202513.97 CNY
9/16/202514.22 CNY
9/15/202514.06 CNY
9/12/202514.37 CNY
9/11/202514.19 CNY
9/10/202514.10 CNY
9/9/202514.21 CNY
9/8/202514.50 CNY
9/5/202514.28 CNY
9/4/202514.07 CNY
9/3/202513.93 CNY
9/2/202514.55 CNY
9/1/202515.14 CNY
8/29/202515.05 CNY
8/28/202515.28 CNY
8/27/202515.49 CNY
8/26/202515.94 CNY
8/25/202516.61 CNY
8/22/202515.79 CNY
8/21/202514.35 CNY
8/20/202514.52 CNY
8/19/202514.60 CNY
8/18/202514.66 CNY
8/15/202514.47 CNY
8/14/202514.41 CNY
8/13/202514.74 CNY
8/12/202514.67 CNY
8/11/202514.97 CNY
8/8/202514.79 CNY
8/7/202515.62 CNY
8/6/202514.84 CNY
8/5/202515.00 CNY
8/4/202514.68 CNY
8/1/202514.68 CNY
7/31/202514.64 CNY
7/30/202513.95 CNY
7/29/202514.15 CNY
7/28/202514.00 CNY
7/25/202514.18 CNY
7/24/202514.32 CNY
7/23/202513.83 CNY
7/22/202513.95 CNY
7/21/202514.22 CNY
7/18/202514.31 CNY
7/17/202514.28 CNY
Access this data via the Eulerpool API
Get Free API Key

Berry Genomics Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
1.17 B CNY
272.10 M CNY
232.70 M CNY
Jan 1, 2018
1.44 B CNY
343.30 M CNY
268.10 M CNY
Jan 1, 2019
1.62 B CNY
433.50 M CNY
390.60 M CNY
Jan 1, 2020
1.54 B CNY
218.00 M CNY
210.70 M CNY
Jan 1, 2021
1.42 B CNY
-46.63 M CNY
-110.82 M CNY
Jan 1, 2022
1.37 B CNY
-125.34 M CNY
-254.78 M CNY
Jan 1, 2023
1.15 B CNY
-197.64 M CNY
-427.20 M CNY
Jan 1, 2024
1.08 B CNY
-121.09 M CNY
-192.43 M CNY

Berry Genomics Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 16, 2026, 11:21 AM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CNY
NET INCOMEM CNY
NET INCOME GROWTH%
SHARESM
2009201020112012201320142015201620172018201920202021202220232024
0.410.460.410.330.260.270.230.921.171.441.621.541.421.371.151.08
43.0113.45-11.85-19.07-20.854.20-15.75300.4327.1422.8912.37-4.76-7.66-3.80-15.86-6.34
12.9611.649.7812.3912.215.863.9162.7661.8358.2361.1052.6044.4442.6944.4846.57
53.0054.0040.0041.0032.0016.009.00578.00724.00838.00988.00810.00632.00584.00512.00502.00
10.008.00––-6.006.00-13.00151.00232.00268.00390.00210.00-110.00-254.00-427.00-192.00
400.00-20.00–––-200.00-316.67-1,261.5453.6415.5245.52-46.15-152.38130.9168.11-55.04
151.20151.20151.20151.20151.20151.20151.20201.40253.00354.60354.60351.10357.48353.52353.52353.52
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Berry Genomics Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Berry Genomics Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Berry Genomics Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Berry Genomics Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Berry Genomics Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Berry Genomics Co stock margins

The Berry Genomics Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Berry Genomics Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Berry Genomics Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
61.83 %
23.23 %
19.87 %
Jan 1, 2018
58.24 %
23.84 %
18.62 %
Jan 1, 2019
61.13 %
26.80 %
24.15 %
Jan 1, 2020
52.62 %
14.15 %
13.68 %
Jan 1, 2021
44.46 %
-3.28 %
-7.79 %
Jan 1, 2022
42.72 %
-9.16 %
-18.62 %
Jan 1, 2023
44.52 %
-17.16 %
-37.10 %
Jan 1, 2024
46.64 %
-11.23 %
-17.85 %

Berry Genomics Co Stock Revenue, EBIT, Earnings per Share

The Berry Genomics Co earnings per share therefore indicates how much revenue Berry Genomics Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
4.63 CNY
1.08 CNY
0.92 CNY
Jan 1, 2018
4.06 CNY
0.97 CNY
0.76 CNY
Jan 1, 2019
4.56 CNY
1.22 CNY
1.10 CNY
Jan 1, 2020
4.39 CNY
0.62 CNY
0.60 CNY
Jan 1, 2021
3.98 CNY
-0.13 CNY
-0.31 CNY
Jan 1, 2022
3.87 CNY
-0.35 CNY
-0.72 CNY
Jan 1, 2023
3.26 CNY
-0.56 CNY
-1.21 CNY
Jan 1, 2024
3.05 CNY
-0.34 CNY
-0.54 CNY

Berry Genomics Co business model & stock analysis

Berry Genomics Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Berry Genomics Co historical P/E ratio, EBIT multiple, and P/S ratio

Berry Genomics Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Berry Genomics Co shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
253.00 M Stocks
Jan 1, 2018
354.60 M Stocks
Jan 1, 2019
354.60 M Stocks
Jan 1, 2020
351.10 M Stocks
Jan 1, 2021
357.48 M Stocks
Jan 1, 2022
353.52 M Stocks
Jan 1, 2023
353.52 M Stocks
Jan 1, 2024
353.52 M Stocks

Berry Genomics Co stock splits

In Berry Genomics Co's history, there have been no stock splits.

Berry Genomics Co Dividend History

1 years of dividend payments

YearAnnual DividendYoY ChangePayments
20010.15CNY—1×

Current Berry Genomics Co forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy83.33 % (5)
Hold16.67 % (1)
Sell0.00 % (0)
12M Price Target
77.27
Last Price
8.30
Currency
CNY
12M Return Potential
830.90 %
LTM Return
0 %

Berry Genomics Co shareholder structure

% Name
12.44677%
Chengdu Tianxing Instrument and Meter (Group) Co., Ltd
Chengdu Tianxing Instrument and Meter (Group) Co., Ltd
8.48605%
Terra Magnum Capital Partners
Terra Magnum Capital Partners
6.04860%
Gao (Yang)
Gao (Yang)
0.76906%
Shanghai Tianyihe Information Technology Co., Ltd.
Shanghai Tianyihe Information Technology Co., Ltd.
0.56574%
Pingtan Tianruiqi Investment Management Partnership (LP)
Pingtan Tianruiqi Investment Management Partnership (LP)
0.56574%
Wang (Baoxia)
Wang (Baoxia)

Berry Genomics Co Executives and Management Board

YG

Mr. Yang Gao

(45)

Chairman of the Board, General Manager · since 2017

Compensation1.22 M CNY
WA

Ms. Wenlu Ai

(37)

Chief Securities Investment Officer

Compensation578,400.00 CNY
DW

Mr. Dong Wang

(51)

Chief Financial Officer, Deputy General Manager, Director · since 2017

Compensation446,300.00 CNY
YL

Mr. Yao Li

(62)

Independent Director

Compensation80,000.00 CNY
HZ

Mr. Hui Zhao

(49)

Director

Compensation33,300.00 CNY

Berry Genomics Co Supply Chain

Berry Genomics Co Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
8 companies
#Name1M3M6M1Y2YTrend
1
Dian Diagnostics Group A
0.23
-0.65
0.24
0.64
0.58
#Name1M3M6M1Y2YTrend
1
Western Mining A
Supplier
-0.41
0.78
0.29
0.15
-0.76
2
Legend Holdings H
Supplier
-0.07
0.43
0.77
0.47
-0.32
3
BioNano Genomics
Supplier
-0.72
0.62
0.80
0.90
-0.31
4
Pacific Biosciences
Supplier
-0.56
0.75
0.82
0.86
-0.24
5
Illumina
Supplier
-0.64
0.70
0.76
0.88
-0.16

Frequently asked questions about Berry Genomics Co

Analysts currently set an average price target of 77.27 CNY for the Berry Genomics Co stock (median: 77.27 CNY), implying +830.9 % versus the latest price. The consensus is based on 6 analyst ratings.

Berry Genomics Co Analyst Price Targets 2026

All fundamentals and in-depth analysis of Berry Genomics Co

Our stock analysis for Berry Genomics Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Berry Genomics Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Berry Genomics Co Stock
Berry Genomics Co Revenue→
Berry Genomics Co Stock
Berry Genomics Co Net Income→
Berry Genomics Co Stock
Berry Genomics Co P/E→
Berry Genomics Co Stock
Berry Genomics Co P/S→
Berry Genomics Co Stock
Berry Genomics Co EBIT→
Berry Genomics Co Stock
Berry Genomics Co Dividend→
Berry Genomics Co Stock
Berry Genomics Co Directors Dealings→
Berry Genomics Co Stock
Berry Genomics Co Stocks→
Berry Genomics Co Stock
Berry Genomics Co Market capitalization→
Berry Genomics Co Stock
Berry Genomics Co Debt→
Berry Genomics Co Stock
Berry Genomics Co Liabilities→
Berry Genomics Co Stock
Berry Genomics Co Equity→
Berry Genomics Co Stock
Berry Genomics Co AAQS→
Berry Genomics Co Stock
Berry Genomics Co Employees→
Berry Genomics Co Stock
Berry Genomics Co ROE→
Berry Genomics Co Stock
Berry Genomics Co ROA→
Berry Genomics Co Stock
Berry Genomics Co ROCE→
Berry Genomics Co Stock
Berry Genomics Co News→
Berry Genomics Co Stock
Berry Genomics Co Analyst Price Targets→

Health Stocks

Beryl DrugsBeOne MedicinesBespoke ExtractsBenQ Medical TechnologyBeta BionicsBenitec BiopharmaBetta Pharmaceuticals CoBen Tre Pharmaceutical JSCBetter TherapeuticsBELLUS HealthBetterLife PharmaBelite Bio Inc ADRAll Stocks A–Z →